SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Bergwerk Dov

(Last)

(First)

(Middle)

C/O TEVA PHARMACEUTICAL INDUSTRIES LTD.,

124 DVORA HANEVI'A STREET

(Street)

TEL AVIV

6944020

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/13/2023

3. Issuer Name and Ticker or Trading Symbol
TEVA PHARMACEUTICAL INDUSTRIES LTD [ TEVA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Acting Chief Legal Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares⁽¹⁾	90,330	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Restricted Share Units	⁽²⁾	⁽²⁾	Ordinary Shares⁽¹⁾	6,653	⁽³⁾	D
Restricted Share Units	⁽⁴⁾	⁽⁴⁾	Ordinary Shares⁽¹⁾	14,587	⁽³⁾	D
Restricted Share Units	⁽⁵⁾	⁽⁵⁾	Ordinary Shares⁽¹⁾	32,036	⁽³⁾	D
Restricted Share Units	⁽⁶⁾	⁽⁶⁾	Ordinary Shares⁽¹⁾	31,075	⁽³⁾	D
Stock Options (right to buy)	⁽⁷⁾	03/12/2024	Ordinary Shares⁽¹⁾	7,501	$48.76	D
Stock Options (right to buy)	⁽⁸⁾	03/12/2025	Ordinary Shares⁽¹⁾	12,753	$60.21	D
Stock Options (right to buy)	⁽⁹⁾	03/17/2026	Ordinary Shares⁽¹⁾	12,754	$53.5	D
Stock Options (right to buy)	⁽¹⁰⁾	03/03/2027	Ordinary Shares⁽¹⁾	17,505	$34.7	D
Stock Options (right to buy)	⁽¹¹⁾	05/24/2027	Ordinary Shares⁽¹⁾	8,755	$28.98	D
Stock Options (right to buy)	⁽¹²⁾	03/02/2028	Ordinary Shares⁽¹⁾	27,501	$19.16	D
Stock Options (right to buy)	⁽¹³⁾	09/18/2027	Ordinary Shares⁽¹⁾	7,010	$16.99	D

Explanation of Responses:

1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

2. Restricted share units were granted on February 28, 2020, with 6,653 vesting on February 28, 2024.

3. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.

4. Restricted share units were granted on March 5, 2021, with 7,293 vesting on March 5, 2024 and 7,294 vesting on March 5, 2025.

5. Restricted share units were granted on March 4, 2022, with 10,678 vesting on each of March 4, 2024 and March 4, 2025 and 10,680 vesting on March 4, 2026.

6. Restricted share units were granted on March 3, 2023, with 7,768 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026 and 7,771 vesting on March 3, 2027.

7. Stock options were granted on March 12, 2014, with 2,500 having vested on each of March 12, 2015 and March 12, 2016 and 2,501 having vested on March 12, 2017.

8. Stock options were granted on March 12, 2015, with 3,188 having vested on each of March 12, 2016, March 12, 2017 and March 12, 2018 and 3,189 having vested on March 12, 2019.

9. Stock options were granted on March 17, 2016, with 3,188 having vested on each of March 17, 2017, March 17, 2018 and March 17, 2019 and 3,190 having vested on March 17, 2020.

10. Stock options were granted on March 3, 2017, with 4,376 having vested on each of March 3, 2018, March 3, 2019 and March 3, 2020 and 4,377 having vested on March 3, 2021.

11. Stock options were granted on May 24, 2017, with 2,188 having vested on each of May 24, 2018, May 24, 2019 and May 24, 2020 and 2,191 having vested on May 24, 2021.

12. Stock options were granted on March 2, 2018, with 6,875 having vested on each of March 2, 2019, March 2, 2020 and March 2, 2021 and 6,876 having vested on March 2, 2022.

13. Restricted share units were granted on September 18, 2017, with 3,505 having vested on each of September 18, 2018 September 18, 2019.

Remarks:

	/s/ Dov Bergwerk	10/18/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.